Moreover, it was found that the levels of CD4+CD25+FOXP3+ Treg cells in the peripheral blood of advanced (stage III-IV) HCC patients were higher than those of early (stage I-II) HCC patients, which implies that the presence of CD4+CD25+ Treg cells was closely related to tumor progression. This evidence concerns the gene FOXP3 and hepatocellular carcinoma.